Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W A Findlay

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 22, 2008
Some important considerations for validation of ligand-binding assaysJohn W A Findlay
The AAPS Journal|October 3, 2007
Appropriate calibration curve fitting in ligand binding assaysJohn W A Findlay, Robert F Dillard
Bioanalysis|January 30, 2014
ISR: background, evolution and implementation, with specific consideration for ligand-binding assaysJohn W A Findlay, Marian M Kelley
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in humanJosh J Yuan, Dai-Chang Yang, Ji Y Zhang, et al.
Pharmaceutical Research|September 1, 2005
Bioanalytical method validation for macromolecules in support of pharmacokinetic studiesJoMarie Smolec, Binodh DeSilva, Wendell Smith, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 22, 2008
Some important considerations for validation of ligand-binding assaysJohn W A Findlay
The AAPS Journal|October 3, 2007
Appropriate calibration curve fitting in ligand binding assaysJohn W A Findlay, Robert F Dillard
Bioanalysis|January 30, 2014
ISR: background, evolution and implementation, with specific consideration for ligand-binding assaysJohn W A Findlay, Marian M Kelley
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in humanJosh J Yuan, Dai-Chang Yang, Ji Y Zhang, et al.
Pharmaceutical Research|September 1, 2005
Bioanalytical method validation for macromolecules in support of pharmacokinetic studiesJoMarie Smolec, Binodh DeSilva, Wendell Smith, et al.
Pageof 1